Should You Buy ATAI Life Sciences NV (ATAI) Stock Monday Morning?

Monday, July 18, 2022 07:05 AM | InvestorsObserver Analysts

Mentioned in this article

ATAI Life Sciences NV (ATAI) has risen Monday morning, with the stock gaining 5.88% in pre-market trading to 4.5. ATAI's short-term technical score of 5 indicates that the stock has traded less bullishly over the last month than 95% of stocks on the market. In the Biotechnology industry, which ranks 131 out of 146 industries, the stock ranks higher than 7% of stocks. ATAI Life Sciences NV has risen 30.77% over the past month, closing at $3.36 on June 20. During this period of time, the stock fell as low as $3.36 and as high as $4.38. ATAI has an average analyst recommendation of Strong Buy. The company has an average price target of $24.67.

ATAI has an Overall Score of 46. Find out what this means to you and get the rest of the rankings on ATAI!
ATAI Life Sciences NV has a Long-Term Technical rank of 49. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 51% of the market scoring higher. In the Biotechnology industry which is number 50 by this metric, ATAI ranks better than 50% of stocks.

Important Dates for Investors in ATAI:

-ATAI Life Sciences NV is set to release earnings on 8/15/2022. Over the last 12 months, the company has reported EPS of $-1.44. -We do not have a set dividend date for ATAI Life Sciences NV at this time. Click Here To Get The Full Report on ATAI Life Sciences NV (ATAI)

Share this article: